It also shapes the tumor microenvironment by promoting regulatory T cell (Treg) activity and myeloid-derived suppressor cell (MDSC) development and alters tumor metabolism by suppressing lactate and IDO expression, thereby preserving T cell function. The gene discussed is IDO1; the disease is neoplasm.